The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
The challenge of antimicrobial resistance: What economics can contribute
Open accessAbstract
Incentivizing restraint in drug use: The accelerating tide of antimicrobial resistance (AMR) is a major worldwide policy concern. Like climate change, the incentives for individual decision-makers do not take into account the costs to society at large. AMR represents an impending “tragedy of the commons,” and there is an immediate need for collective action to prevent future harm. Roope et al. review the issues associated with AMR from an economics perspective and draw parallels with climate change. A major stumbling block for both challenges is to build consensus about the best way forward when faced with many uncertainties and inequities. Science , this issue p. eaau4679
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hardin, G. (1968) · Science · doi:10.1126/science.162.3859.1243 · Cited by 25,167
(2007) · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · Cited by 9,690
The Economics of Climate Change: The Stern Review
Stern, N. (2007) · doi:10.1017/cbo9780511817434 · Cited by 8,371
Time Discounting and Time Preference: A Critical Review
Frederick, S., Loewenstein, G. F., & O’Donoghue, T. (2002) · Journal of Economic Literature · doi:10.1257/002205102320161311 · Cited by 6,381
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Klein, E. Y., Van Boeckel, T. P., Martinez, E. M., Pant, S., Gandra, S., Levin, S. A., Goossens, H., & Laxminarayan, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717295115 · Cited by 3,232
Irreversible climate change due to carbon dioxide emissions
Solomon, S., Plattner, G.-K., Knutti, R., & Friedlingstein, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812721106 · Cited by 3,217
Liu, L., Oza, S., Hogan, D., Perin, J., Rudan, I., Lawn, J. E., Cousens, S., Mathers, C., & Black, R. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61698-6 · Cited by 3,167
(2016) · Cited by 2,888
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
(2012) · RePEc: Research Papers in Economics · Cited by 1,951
On Modeling and Interpreting the Economics of Catastrophic Climate Change
Weitzman, M. L. (2009) · Review of Economics and Statistics · doi:10.1162/rest.91.1.1 · Cited by 1,791 · cited 1×
“These uncertainties have ledmany economists, such as Stern (80), to caution against an overly narrow focus on cost-benefit approaches to climate changemitigation and to call for more drastic and imminent emission reductions as insurance against the non-negligible possibility of catastrophic outcomes (81, 82).”
BackgroundWill 10 Million People Die a Year due to Antimicrobial Resistance by 2050?
de Kraker, M. E. A., Stewardson, A. J., & Harbarth, S. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002184 · Cited by 1,596
Access to effective antimicrobials: a worldwide challenge
Laxminarayan, R., Matsoso, P., Pant, S., Brower, C., Røttingen, J.-A., Klugman, K., & Davies, S. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00474-2 · Cited by 1,465
Revisiting the social cost of carbon
Nordhaus, W. D. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609244114 · Cited by 1,366
Climate Change Policy: What Do the Models Tell Us?
Pindyck, R. S. (2013) · Journal of Economic Literature · doi:10.1257/jel.51.3.860 · Cited by 946
Tang, K. L., Caffrey, N. P., Nóbrega, D. B., Cork, S. C., Ronksley, P. E., Barkema, H. W., Polachek, A. J., Ganshorn, H., Sharma, N., Kellner, J. D., et al. (2017) · The Lancet Planetary Health · doi:10.1016/s2542-5196(17)30141-9 · Cited by 942
Reducing antimicrobial use in food animals
Van Boeckel, T. P., Glennon, E. E., Chen, D., Gilbert, M., Robinson, T. P., Grenfell, B. T., Levin, S. A., Bonhoeffer, S., & Laxminarayan, R. (2017) · Science · doi:10.1126/science.aao1495 · Cited by 807
Collignon, P., Beggs, J. J., Walsh, T. R., Gandra, S., & Laxminarayan, R. (2018) · The Lancet Planetary Health · doi:10.1016/s2542-5196(18)30186-4 · Cited by 750
Extreme vulnerability of smallholder farmers to agricultural risks and climate change in Madagascar
Harvey, C. A., Rakotobe, Z. L., Rao, N. S., Dave, R., Razafimahatratra, H., Rabarijohn, R. H., Rajaofara, H., & MacKinnon, J. L. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0089 · Cited by 720
Multidrug evolutionary strategies to reverse antibiotic resistance
Baym, M., Stone, L. K., & Kishony, R. (2016) · Science · doi:10.1126/science.aad3292 · Cited by 710
The collective-risk social dilemma and the prevention of simulated dangerous climate change
Milinski, M., Sommerfeld, R. D., Krambeck, H.-J., Reed, F. A., & Marotzke, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709546105 · Cited by 610
Huttner, B., Goossens, H., Verheij, T., & Harbarth, S. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70305-6 · Cited by 574
Estimating the burden of antimicrobial resistance: a systematic literature review
Naylor, N. R., Atun, R., Zhu, N., Kulasabanathan, K., Silva, S., Chatterjee, A., Knight, G. M., & Robotham, J. V. (2018) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-018-0336-y · Cited by 568
Self-citationAntibiotic resistance increases with local temperature
MacFadden, D. R., McGough, S. F., Fisman, D., Santillana, M., & Brownstein, J. S. (2018) · Nature Climate Change · doi:10.1038/s41558-018-0161-6 · Cited by 560
Fat-Tailed Uncertainty in the Economics of Catastrophic Climate Change
Weitzman, M. L. (2011) · Review of Environmental Economics and Policy · doi:10.1093/reep/rer006 · Cited by 517
Antibiotic Resistance — Problems, Progress, and Prospects
Nathan, C., & Cars, O. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1408040 · Cited by 491
The true cost of antimicrobial resistance
Smith, R., & Coast, J. (2013) · BMJ · doi:10.1136/bmj.f1493 · Cited by 488
Self-citationEnne, V. I., Livermore, D. M., Stephens, P., & Hall, L. M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04519-0 · Cited by 486
Karanika, S., Paudel, S., Grigoras, C., Kalbasi, A., & Mylonakis, E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00825-16 · Cited by 402
Teillant, A., Gandra, S., Barter, D., Morgan, D. J., & Laxminarayan, R. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00270-4 · Cited by 379
Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa
Keenan, J. D., Bailey, R. L., West, S. K., Arzika, A. M., Hart, J., Weaver, J., Kalua, K., Mrango, Z., Ray, K. J., Cook, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1715474 · Cited by 360
Luepke, K. H., Suda, K. J., Boucher, H., Russo, R. L., Bonney, M. W., Hunt, T. D., & Mohr, J. F. (2017) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1868 · Cited by 344
Economics: Current climate models are grossly misleading
Stern, N. (2016) · Nature · doi:10.1038/530407a · Cited by 317
Butler, C. C., Simpson, S. A., Dunstan, F., Rollnick, S., Cohen, D., Gillespie, D., Evans, M. R., health, S. L. I. E. A. P., Alam, M. F., Bekkers, M.-J., et al. (2012) · BMJ · doi:10.1136/bmj.d8173 · Cited by 316
Self-citationAchieving global targets for antimicrobial resistance
Laxminarayan, R., Sridhar, D., Blaser, M., Wang, M., & Woolhouse, M. (2016) · Science · doi:10.1126/science.aaf9286 · Cited by 315
Shrestha, P., Cooper, B. S., Coast, J., Oppong, R., Do Thi Thuy, N., Phodha, T., Celhay, O., Guerin, P. J., Wertheim, H., & Lubell, Y. (2018) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-018-0384-3 · Cited by 288
Angell, M. (1993) · Kennedy Institute of Ethics Journal · doi:10.1353/ken.0.0253 · Cited by 257
Cogliani, C., Goossens, H., & Greko, C. (2011) · Microbe Magazine · doi:10.1128/microbe.6.274.1 · Cited by 253
Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms
Hughes, D., & Andersson, D. I. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3922 · Cited by 245
Antimicrobial resistance: a global response.
Smith, R., & Coast, J. (2002) · Europe PMC (PubMed Central) · Cited by 222
Self-citationHsia, Y., Sharland, M., Jackson, C., Wong, I. C. K., Magrini, N., & Bielicki, J. A. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30547-4 · Cited by 205
Mendelson, M., Røttingen, J.-A., Gopinathan, U., Hamer, D. H., Wertheim, H., Basnyat, B., Butler, C., Tomson, G., & Balasegaram, M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00547-4 · Cited by 204
Self-citationActual versus ‘ideal’ antibiotic prescribing for common conditions in English primary care
Pouwels, K. B., Dolk, F. C. K., Smith, D. R. M., Robotham, J. V., & Smieszek, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx502 · Cited by 201
Self-citationEconomics of Antibiotic Resistance: A Theory of Optimal Use
Laxminarayan, R., & Brown, G. M. (2001) · Journal of Environmental Economics and Management · doi:10.1006/jeem.2000.1156 · Cited by 189
Adapting to climate change in small island developing states
Betzold, C. (2015) · Climatic Change · doi:10.1007/s10584-015-1408-0 · Cited by 188
Addressing antibiotic abuse in China: An experimental audit study
Currie, J., Lin, W., & Meng, J. (2014) · Journal of Development Economics · doi:10.1016/j.jdeveco.2014.05.006 · Cited by 187
Sundqvist, M., Geli, P., Andersson, D. I., Sjolund-Karlsson, M., Runehagen, A., Cars, H., Abelson-Storby, K., Cars, O., & Kahlmeter, G. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp387 · Cited by 179
Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure
Enne, V. I. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh217 · Cited by 171
Estimates of the Social Cost of Carbon: Background and Results from the RICE-2011 Model
Nordhaus, W. (2011) · National Bureau of Economic Research · doi:10.3386/w17540 · Cited by 169
Agency in health care: Getting beyond first principles
Mooney, G., & Ryan, M. (1993) · Journal of Health Economics · doi:10.1016/0167-6296(93)90023-8 · Cited by 164
Policy: An intergovernmental panel on antimicrobial resistance
Woolhouse, M. E. J., & Farrar, J. (2014) · Nature · doi:10.1038/509555a · Cited by 162
Preserving Antibiotics, Rationally
Hollis, A., & Ahmed, Z. (2013) · New England Journal of Medicine · doi:10.1056/nejmp1311479 · Cited by 160
International cooperation to improve access to and sustain effectiveness of antimicrobials
Årdal, C., Outterson, K., Hoffman, S. J., Ghafur, A. K., Sharland, M., Ranganathan, N., Smith, R., Zorzet, A., Cohn, J., Pittet, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00470-5 · Cited by 159
Self-citationUsing and improving the social cost of carbon
Pizer, W., Adler, M., Aldy, J., Anthoff, D., Cropper, M., Gillingham, K., Greenstone, M., Murray, B., Newell, R., Richels, R., et al. (2014) · Science · doi:10.1126/science.1259774 · Cited by 158
Does High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?
Day, T., & Read, A. F. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004689 · Cited by 148
Public health: The politics of antibiotics
Cully, M. (2014) · Nature · doi:10.1038/509s16a · Cited by 146
Repairing The Broken Market For Antibiotic Innovation
Outterson, K., Powers, J. H., Daniel, G. W., & McClellan, M. (2015) · Health Affairs · doi:10.1377/hlthaff.2014.1003 · Cited by 142
Jain, S., Jain, P., Moghe, V. V., et al. (2015) · Perspectives in Clinical Research · doi:10.4103/2229-3485.154005 · Cited by 141
Tail-Hedge Discounting and the Social Cost of Carbon
Weitzman, M. L. (2013) · Journal of Economic Literature · doi:10.1257/jel.51.3.873 · Cited by 141
Coenen, S., Francis, N. A., Kelly, M. J., Hood, K., Nuttall, J., Little, P. S., Verheij, T. J., Melbye, H., Goossens, H., Butler, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076691 · Cited by 140
Self-citationSuperbugs: Should antimicrobial resistance be included as a cost in economic evaluation?
Coast, J., Smith, R., & Millar, M. R. (1996) · Health Economics · Cited by 138
Self-citationButler, C., Hillier, S. L., Roberts, Z., Dunstan, F., Howard, A., & Palmer, S. (2006) · Europe PMC (PubMed Central) · Cited by 134
Self-citationGlobal progress and backsliding on gasoline taxes and subsidies
Ross, M. L., Hazlett, C. J., & Mahdavi, P. (2017) · Nature Energy · doi:10.1038/nenergy.2016.201 · Cited by 131
Smith, R. D. J., Yago, M., Millar, M., & Coast, J. (2005) · Journal of Health Economics · doi:10.1016/j.jhealeco.2005.02.003 · Cited by 130
Self-citationKelly, R., Zoubiane, G., Walsh, D., Ward, R. H. R., & Goossens, H. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00350-3 · Cited by 118
Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach
Rex, J. H., & Outterson, K. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00500-9 · Cited by 113
Butler, C., Dunstan, F., Heginbothom, M. L., Mason, B. W., Roberts, Z., Hillier, S. L., Howe, R. A., Palmer, S., & Howard, A. (2007) · Europe PMC (PubMed Central) · Cited by 112
Self-citationHopkins, S., Müller‐Pebody, B., Guy, R. L., Gerver, S. M., Ironmonger, D., Puleston, R. L., Loutet, M. G., Lalor, M. K., Davidson, J. A., Mohiyuddin, T., et al. (2014) · doi:10.13140/2.1.1227.5208 · Cited by 109
Inpatient Antimicrobial Stewardship in Pediatrics: A Systematic Review
Smith, M. J., Gerber, J. S., & Hersh, A. L. (2015) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piu141 · Cited by 106
Novel Approaches Are Needed to Develop Tomorrow’s Antibacterial Therapies
Spellberg, B. J., Bartlett, J., Wunderink, R. G., & Gilbert, D. N. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1894oe · Cited by 102
Influence of population density on antibiotic resistance
Bruinsma, N. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg072 · Cited by 98
Pouwels, K. B., Freeman, R., Müller‐Pebody, B., Rooney, G., Henderson, K. L., Robotham, J. V., & Smieszek, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky031 · Cited by 89
Self-citationAn economic perspective on policy to reduce antimicrobial resistance
Coast, J., Smith, R., & Millar, M. R. (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(97)00132-9 · Cited by 86
Self-citationAllen, M. R., & Frame, D. J. (2007) · Science · doi:10.1126/science.1149988 · Cited by 85
Gonzales, R., Corbett, K. K., Leeman-Castillo, B. A., Glazner, J. E., Erbacher, K., Darr, C. A., Wong, S. L., Maselli, J. H., Sauaia, A., & Kafadar, K. (2005) · Health Services Research · doi:10.1111/j.1475-6773.2005.00344.x · Cited by 84
Outterson, K., Gopinathan, U., Clift, C., So, A. D., Morel, C. M., & Røttingen, J.-A. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002043 · Cited by 79
Communicating trends in resistance using a drug resistance index
Laxminarayan, R., & Klugman, K. P. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000135 · Cited by 76
Science advice for global challenges: Learning from trade-offs in the IPCC
Pearce, W., Mahony, M., & Raman, S. (2017) · Environmental Science & Policy · doi:10.1016/j.envsci.2017.11.017 · Cited by 73
MacLean, R. C., & Vogwill, T. (2014) · Evolution Medicine and Public Health · doi:10.1093/emph/eou032 · Cited by 67
What are the economic barriers of antibiotic R&D and how can we overcome them?
Renwick, M. J., & Mossialos, E. A. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1515908 · Cited by 61
Antibiotic Resistance is a Tragedy of the Commons That Necessitates Global Cooperation
Hollis, A., & Maybarduk, P. (2015) · The Journal of Law Medicine & Ethics · doi:10.1111/jlme.12272 · Cited by 59
Roope, L. S. J., Tonkin-Crine, S. K., Butler, C., Crook, D. W., Peto, T., Peters, M., Walker, A. S., & Wordsworth, S. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.25.1700424 · Cited by 56
Self-citationAssessing the impact of national antibiotic campaigns in Europe
Filippini, M., Ortiz, L. G. G., & Masiero, G. (2013) · The European Journal of Health Economics · doi:10.1007/s10198-012-0404-9 · Cited by 55
Årdal, C., Findlay, D. M., Savić, M., Carmeli, Y., Gyssens, I. C., Laxminarayan, R., Outterson, K., & Rex, J. H. (2018) · NORA - Norwegian Open Research Archives · Cited by 51
Antibiotics: achieving the balance between access and excess
Das, P., & Horton, R. C. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00729-1 · Cited by 41
New Drugs to Tackle Antimicrobial Resistance: Analysis of EU Policy OptionsPreprint
Sharma, P., & Towse, A. (2010) · SSRN Electronic Journal · doi:10.2139/ssrn.2640028 · Cited by 39
Lishman, H., Costelloe, C., Hopkins, S., Johnson, A. P., Hope, R., Guy, R. L., Müller‐Pebody, B., Holmes, A. H., & Aylin, P. P. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.08.013 · Cited by 31
Dik, J.-W. H., Hendrix, R., Friedrich, A. W., Luttjeboer, J., Panday, P. V. N., Wilting, K. R., Foe, J. R. L. T., Postma, M. J., & Sinha, B. N. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126106 · Cited by 30
The 2018 Garrod Lecture: Preparing for the Black Swans of resistance
Livermore, D. M. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky265 · Cited by 27
Antibiotic consumption and the role of dispensing physicians
Filippini, M., Heimsch, F., & Masiero, G. (2014) · Regional Science and Urban Economics · doi:10.1016/j.regsciurbeco.2014.07.005 · Cited by 17
Distributional Considerations in Economic Responses to Antimicrobial Resistance
Coast, J., & Smith, R. (2015) · Public Health Ethics · doi:10.1093/phe/phv004 · Cited by 7
Self-citation
Cited by
Metal complexes as a promising source for new antibiotics
Frei, A., Zuegg, J., Elliott, A. G., Baker, M., Braese, S., Brown, C., Chen, F., G. Dowson, C., Dujardin, G., Jung, N., et al. (2020) · Chemical Science · doi:10.1039/c9sc06460e · Cited by 543
The role of vaccines in combatting antimicrobial resistance
Micoli, F., Bagnoli, F., Rappuoli, R., & Serruto, D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00506-3 · Cited by 500
Magnano San Lio, R., Favara, G., Maugeri, A., Barchitta, M., & Agodi, A. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20031681 · Cited by 440
Innovative and rapid antimicrobial susceptibility testing systems
van Belkum, A., Burnham, C.-A. D., Rossen, J. W. A., Mallard, F., Rochas, O., & Dunne, W. M. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0327-x · Cited by 355
A novel antibiotic class targeting the lipopolysaccharide transporter
Zampaloni, C., Mattei, P., Bleicher, K., Winther, L., Thäte, C., Bucher, C., Adam, J.-M., Alanine, A., Amrein, K. E., Baidin, V., et al. (2024) · Nature · doi:10.1038/s41586-023-06873-0 · Cited by 308
Metadata
- Authors
- Roope, L. S. J., Smith, R. D., Pouwels, K. B., Buchanan, J., Abel, L., Eibich, P., Butler, C. C., Tan, P. S., Walker, A. S., Robotham, J. V., & Wordsworth, S.
- Venue
- Science
- Published
- 2019-04-05
- Volume
- 364
- Issue
- 6435
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2932477481
- Cited by
- 575
- References
- 92
- FWCI
- 34.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.